Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma

Clinical trial NCT00072345 · COMPLETED

Trial details

NCT number: NCT00072345
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Intraocular Melanoma Melanoma (Skin)

Start date: 2003-07-01
Primary completion: 2004-08-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.